Investing firm Assured Healthcare Partners and West Long Branch, N.J.-based Allied Digestive Health struck a deal Jan. 13. Matt Jameson, managing director of Assured Healthcare Partners, and Bob Gialanella, MD, president and CEO of Allied Digestive Health, elaborated on the deal and offered insights into the platform’s future. Note: Responses were edited for style and content. Question: With several private equity-backed gastroenterologist platforms in the space, how will you stand out from the competition? Matt Jameson: ADH has always been a physician-centric organization with high quality standards. ADH’s partnership model will continue to help high-quality gastroenterologists in New Jersey and surrounding…
Author: Praveen Suthrum
FREDERICKSBURG, Va., Jan. 19, 2021 /PRNewswire/ — Physicians Endoscopy (PE) along with physicians of Gastroenterology Associates of Fredericksburg and Mary Washington Healthcare are excited to announce their three-way joint venture partnership and opening of Fredericksburg Endoscopy Center, LLC, located at 1211 Central Park Boulevard, Fredericksburg, VA. Fredericksburg Endoscopy Center, LLC includes 9,000 square feet and four procedure rooms, allowing for the endoscopic ambulatory surgery center to provide a high volume of procedures—an expected 14,000 annually.
GI Alliance partnered with ObvioHealth, a research organization, to create decentralized clinical trial designs, according to a Jan. 19 news release. The move pairs ObvioHealth’s virtual trial capabilities with GI Alliance’s research network to facilitate safer hybrid clinical trials, the release said. “This partnership helps alleviate many of the burdensome requirements of clinical trials, allowing our physicians to concentrate on patient care and better support them through the clinical trial journey,” Tim Ritter, MD, senior research medical director of GI Alliance, said in the release.
Between presenting at the 39th Annual JP Morgan Healthcare Conference, acquiring an asset that boosted its precision oncology line, and presenting its preliminary fourth-quarter 2020 results, Exact Sciences had a busy week. Five things Exact did this week: 1. Chair and CEO Kevin Conroy gave a series of updates Jan. 13 at the JP Morgan Healthcare Conference, Genome Web reported Jan. 14. Mr. Conroy said Exact tested more than 4 million people in 2020, contributing to the $1.49 billion in preliminary 2020 revenues the company reported Jan. 10. 2. Mr. Conroy reiterated Exact’s goal to be a leader in three diagnostic screening markets: colorectal…
On November 30th, 2020, Troy Gastroenterology (Michigan) announced its partnership with H.I.G. Growth Partners to launch the seventh private equity platform in GI: Pinnacle GI Partners. Dr. Partha Nandi is the President, Practice CEO and Executive Chair of the Board of the new platform. In this insightful interview, he shares why it’s still an early inning for private equity in gastroenterology, how they chose their PE partner and discusses challenges with EBITDA expectations. Listen to this exclusive deep dive into GI’s latest PE platform.
Memphis, Tenn.-based One GI ended 2020 with a pair of post-formation deals and has no plans of stopping as 2021 kicks off. Michael Dragutsky, MD, chair of One GI, spoke with Becker’s ASC Review about the state of the platform and elaborated on what’s in store for private equity in 2021. Note: Responses have been edited for style and content. Question: What do you think has fueled your growth so quickly? Dr. Michael Dragutsky: It’s several things. I think it’s a vision of regional density. We’re real believers in that. To drive leverage with the payers and have clout, you have to do…
Although functional gastrointestinal disorders (FGIDs), now called disorders of gut-brain interaction, have major economic effects on health care systems and adversely affect quality of life, little is known about their global prevalence and distribution. We investigated the prevalence of and factors associated with 22 FGIDs, in 33 countries on 6 continents.
The CEO of Covid-19 vaccine maker Moderna warned Wednesday that the coronavirus that has brought world economies to a standstill and overwhelmed hospitals will be around “forever.” Public health officials and infectious disease experts have said there is a high likelihood that Covid-19 will become an endemic disease, meaning it will become present in communities at all times, though likely at lower levels than it is now.
Women who adhered to an anti-reflux lifestyle had a decreased risk for gastroesophageal reflux disease symptoms, possibly preventing up to 40% of symptoms that occur weekly, according to study results. “Adherence to an anti-reflux lifestyle, even among regular users of PPIs and/or [H2 receptor antagonists], was associated with a decreased risk of GERD symptoms and may prevent nearly 40%of GERD symptoms that occur at least weekly,” Raaj S. Mehta, MD, from the Clinical and Translational Epidemiology unit, Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues wrote. “[GERD] is more common in white women aged 30 to 60 years. These data…
For the second year in a row, mortality from cancer has fallen in the United States, driven largely by reductions in the incidence of, and death from, non-small cell lung cancer (NSCLC) in men and women, according to a new report from the American Cancer Society.